Communicators

EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company" - https://www.commodity-tv.com/play/enwave-targeting-profitability-in-2020-signed-joint-development-deal-with-gea-lyophil/ ), a global leader in vacuum microwave dehydration technology, announced today that it has received nine recent patent approvals from a number of key international patent offices. Currently the Company has fifteen patent families related to its Radiant Energy Vacuum (“REV™”) technology that have been approved in multiple international jurisdictions.  Also, EnWave has six patent applications that have been completed and submitted to the international Patent Cooperation Treaty (“PCT”) examiner for review and potential approval for national phase pursuit.

Within the past three months EnWave has received approvals from the Chilean, Indonesian and Mexican patent offices for its Modular nutraREV® patent, approval from the Brazilian patent office for its vaccine processing patent, approvals from both the Australian and Canadian patent offices for its Frozen-In process patent, approval from the United States patent office for the quantaREV® apparatus patent, approval from the Australian patent office for the vacuum-microwaved puffed-snack patent and most importantly, patent approval from the Canadian patent office for the dehydration and decontamination of cannabis using REV™ technology. The Company has a large amount of additional pending national phase applications that should be approved in the coming months.

EnWave’s distinctive excellence is that the Company offers the most scalable and reliable proprietary vacuum-microwave technology with the most comprehensive set of innovations and solutions available, which accelerates product and process development and unlocks value for our global partners.

About EnWave

EnWave Corporation, a Vancouver-based advanced technology company, has developed Radiant Energy Vacuum (“REV™”) – an innovative, proprietary method for the precise dehydration of organic materials. EnWave has further developed patent-pending methods for uniformly drying and decontaminating cannabis through the use of REV™ technology, shortening the time from harvest to marketable cannabis products. 

REV™ technology’s commercial viability has been demonstrated and is growing rapidly across several market verticals in the food, and pharmaceutical sectors, including legal cannabis. EnWave’s strategy is to sign royalty-bearing commercial licenses with innovative, disruptive companies in multiple verticals for the use of REV™ technology. The company has signed over thirty royalty-bearing licenses to date. In addition to these licenses, EnWave established a Limited Liability Corporation, NutraDried Food Company, LLC, to manufacture, market and sell all-natural dairy snack products in the United States, including the Moon Cheese® brand. 

EnWave has introduced REV™ as a disruptive dehydration platform in the food and cannabis sectors: faster and cheaper than freeze drying, with better end product quality than air drying or spray drying. EnWave currently offers two distinct commercial REV™ platforms:

1. nutraREV® which is a drum-based system that dehydrates organic materials quickly and at low-cost, while maintaining high levels of nutrition, taste, texture and colour; and,

2.   quantaREV® which is a tray-based system used for continuous, high-volume low-temperature drying.

More information about EnWave is available at www.enwave.net.

EnWave Corporation

Mr. Brent Charleton, CFA

President and CEO

For further information:

Brent Charleton, CFA , President and CEO at +1 (778) 378-9616

E-mail: bcharleton@enwave.net     

Dan Henriques, CFO at +1 (604) 835-5212

E-mail: dhenriques@enwave.net  

Deborah Honig, Corporate Development at + 1 (647) 203-8793

E-mail: dhonig@enwave.net

In Europe:

Swiss Resource Capital AG

Jochen Staiger

info@resource-capital.ch

www.resource-capital.ch

Forward-Looking Information: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's proposed expansion into the U.S. cannabis market, are forward-looking statements. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions, including that such expansion efforts may not meet the expectations of management of the Company, that applicable laws may change to become more restrictive on the Company's proposed business expansion, that the Company may be exposed to legal and regulatory risk, including fines, penalties or other sanctions, and other risks identified in the Company's public filings, all of which may have a material adverse effect on the Company's ability to pursue the proposed business expansion strategy and the Company's business as a whole. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company does not undertake any obligation to update any forward-looking information, except as required by applicable securities law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.